反应 #1256766

ord-3c7fdf0354cc444bae5cf58358ff9bfa

反应方程式

CCOC(=O)C1CCN(S(=O)(=O)c2ccc(C)cc2)c2ccccc2C1=O
5-oxo-1-(toluene-4-sulfonyl)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylic acid ethyl ester
O=C1c2ccccc2C(=O)N1CCBr
N-(2-bromoethyl)phthalimide
CCOC(=O)C1(CCN2C(=O)c3ccccc3C2=O)CCN(S(=O)(=O)c2ccc(C)cc2)c2ccccc2C1=O
title compound
CCOC(=O)C1(CCN2C(=O)c3ccccc3C2=O)CCN(S(=O)(=O)c2ccc(C)cc2)c2ccccc2C1=O
4-[2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-ethyl]-5-oxo-1-(toluene-4-sulfonyl)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylic acid ethyl ester

反应条件

详细条件
See reaction.notes.procedure_details.

实验过程

The title compound was prepared from 5-oxo-1-(toluene-4-sulfonyl)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylic acid ethyl ester and N-(2-bromoethyl)phthalimide as described in Example 1. 1H NMR (CDCl3) δ 7.85 (m, 4H), 7.75 (m, 4H), 7.55-7.45 (m, 2H), 7.4-7.35 (m, 1H), 7.25-7.2 (m, 1H), 4.2-4.0 (m, 6H), 3.9-3.85 (m, 1H), 3.65-3.55 (m, 3H), 3.4 (br s, 1H), 2.4 (s, 3H), 2.4-2.35 (m, 1H), 1.35-1.15 (m, 3H). MS (ES) m/z 583 (MNa)+

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US07825111B2uspto-grants-2010_11